Top Markets
#1 Seeker Seeker +118.45%
#2 AI XOVIA AI XOVIA +109.92%
#3 MowCat MowCat +107.21%
#4 Helium Helium +79.69%
#5 Pons Pons +48.98%
#6 UnifAI Network UnifAI Network +38.31%
#7 Zora Zora +33.18%
#8 Zylo Ecosystem Zylo Ecosystem +20.99%
#9 Bounce Bounce +20.57%
#10 Tensor Tensor +17.68%
Coin of the day
Seeker Seeker
Setări
Limbă
ROMâNă
Monedă
USD
Temă
BridgeBio Oncology Therapeutics Inc. BridgeBio Oncology Therapeutics Inc.

BridgeBio Oncology Therapeutics Inc.

BBOT
Rang în acțiuni #11444
BridgeBio Oncology Therapeutics functions as a clinical-stage biopharmaceutical... BridgeBio Oncology Therapeutics functions as a clinical-stage biopharmaceutical firm dedicated to pioneering advanced small molecule treatments. These therapies are aimed at combating malignancies driven by RAS and PI3Kα, both frequently encountered oncogenes in human cancers. Initially established as an offshoot of BridgeBio Pharma, the company concentrates on precision oncology. Its developmental pipeline features several promising programs, including BBO-8520, BBO-10203, and BBO-11818, all specifically designed to modulate the KRAS and PI3K pathways. The company recently became publicly traded through a business combination with Helix Acquisition Corp. II. This strategic move successfully raised approximately $450 million, which will be utilized to further its clinical development initiatives. The leadership team comprises Dr. Eli Wallace as Chief Executive Officer and Dr. Pedro Beltran as Chief Scientific Officer.
Preț acțiune
$8.74
Ultima sincronizare: 2026-08-28
Capitalizare de piață
$699.74M
Schimbare (1 zi)
-4.85%
Schimbare (1 an)
-2.29%
Țară
US
Tranzacționează BridgeBio Oncology Therapeutics Inc. (BBOT)

Categorie

Healthcare
Venituri pentru BridgeBio Oncology Therapeutics Inc. (BBOT)
Venituri în Aug 2026 TTM: 0
Conform celor mai recente rapoarte financiare ale BridgeBio Oncology Therapeutics Inc., venitul actual al companiei (TTM) este 0. În anul 2026, compania a avut un venit de 0 egal cu venitul din anul 2026, care a fost de 0. Venitul reprezintă suma totală generată de o companie din vânzarea de bunuri sau servicii. Spre deosebire de profit, cheltuielile nu sunt scăzute.
Istoricul veniturilor pentru BridgeBio Oncology Therapeutics Inc. din 2026 până în 2026
Venituri la sfârșitul fiecărui an
An Venituri Schimbă
Nu sunt suficiente date pentru perioada selectată.
Venituri pentru companii similare sau concurente
Companie Venituri Diferență de venituri Țara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH